Document is current
Any future updates will be listed below
-
Authors
Chong, Pui Lin https://orcid.org/0000-0002-7747-4162
Laight, David
Aspinall, Richard J.
Higginson, Antony
Cummings, Michael H.
-
Clinical Trials BETA
Clinical trials referenced in this document:
isrctn05474560 at ISRCTN.orgDocuments that mention this clinical trial
A randomised placebo controlled trial of VSL#3® probiotic on biomarkers of cardiovascular risk and liver injury in non-alcoholic fatty liver disease
https://doi.org/10.1186/s12876-021-01660-5
-
Funding
Funding for this research was provided by:
Actial Farmaceutica, Italy
Portsmouth Hospitals NHS Trust
- License Information
-
More Information
Article History
Received: 12 August 2019
Accepted: 9 February 2021
First Online: 1 April 2021
Ethics approval and consent to participate
: Ethical approval was granted by NRES Committee South Central—Hampshire B (Ref. 11/SC/0532) and written informed consent was obtained from all eligible patients.
: Not applicable.
: The authors have nothing to declare.
